Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malerczyk

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Growth Factors (Chur, Switzerland)|June 1, 2000
Tissue distribution and retinoid-mediated downregulation of an FGF-binding protein (FGF-BP) in the ratA Aigner, C Malerczyk, R Houghtling, et al.
Pharmatherapeutica|January 1, 1989
Absence of interaction between ramipril, a new ACE-inhibitor, and phenprocoumon, an anticoagulant agentM Verho, V Malerczyk, H Grötsch, et al.
Drugs Under Experimental and Clinical Research|January 1, 1988
Absence of crystalluria and estimation of renal parameters after oral and intravenous ofloxacin as compared to placebo in healthy volunteersM Verho, V Malerczyk, H Grötsch, et al.
Drug Metabolism and Drug Interactions|January 1, 1996
Pharmacokinetics of levofloxacin in comparison to the racemic mixture of ofloxacin in manM Verho, V Malerczyk, D Damm, et al.
Human Vaccines|April 28, 2010
Rabies in South Africa and the FIFA Soccer World Cup: travelers' awareness for an endemic but neglected diseaseClaudius Malerczyk, Louis H Nel, Dieter Gniel, et al.
International Journal of Cancer|May 8, 2000
ERbB-2 expression is rate-limiting for epidermal growth factor-mediated stimulation of ovarian cancer cell proliferationS S Hsieh, C Malerczyk, A Aigner, et al.
Arzneimittel-Forschung|January 1, 1979
[Studies on the competition of several antibiotics for binding sites to serum protein (author's transl)]V Malerczyk, W Ruegenberg, K U Seiler, et al.
Toxicology|April 27, 2000
Reversal of HER-2 over-expression renders human ovarian cancer cells highly resistant to taxolA Aigner, S S Hsieh, C Malerczyk, et al.
Oncogene|November 13, 2001
The human papillomavirus (HPV) 16 E6 oncoprotein leads to an increase in gene expression of the angiogenic switch molecule FGF-BP in non-immortalized human keratinocytesH Stöppler, C Malerczyk, K Block, et al.
Zeitschrift Fur Kardiologie|June 1, 1975
[Oxygen transport in the blood of children with congenital heart defects]H Manzke, W Esters, K Dörner, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Growth Factors (Chur, Switzerland)|June 1, 2000
Tissue distribution and retinoid-mediated downregulation of an FGF-binding protein (FGF-BP) in the ratA Aigner, C Malerczyk, R Houghtling, et al.
Pharmatherapeutica|January 1, 1989
Absence of interaction between ramipril, a new ACE-inhibitor, and phenprocoumon, an anticoagulant agentM Verho, V Malerczyk, H Grötsch, et al.
Drugs Under Experimental and Clinical Research|January 1, 1988
Absence of crystalluria and estimation of renal parameters after oral and intravenous ofloxacin as compared to placebo in healthy volunteersM Verho, V Malerczyk, H Grötsch, et al.
Drug Metabolism and Drug Interactions|January 1, 1996
Pharmacokinetics of levofloxacin in comparison to the racemic mixture of ofloxacin in manM Verho, V Malerczyk, D Damm, et al.
Human Vaccines|April 28, 2010
Rabies in South Africa and the FIFA Soccer World Cup: travelers' awareness for an endemic but neglected diseaseClaudius Malerczyk, Louis H Nel, Dieter Gniel, et al.
International Journal of Cancer|May 8, 2000
ERbB-2 expression is rate-limiting for epidermal growth factor-mediated stimulation of ovarian cancer cell proliferationS S Hsieh, C Malerczyk, A Aigner, et al.
Arzneimittel-Forschung|January 1, 1979
[Studies on the competition of several antibiotics for binding sites to serum protein (author's transl)]V Malerczyk, W Ruegenberg, K U Seiler, et al.
Toxicology|April 27, 2000
Reversal of HER-2 over-expression renders human ovarian cancer cells highly resistant to taxolA Aigner, S S Hsieh, C Malerczyk, et al.
Oncogene|November 13, 2001
The human papillomavirus (HPV) 16 E6 oncoprotein leads to an increase in gene expression of the angiogenic switch molecule FGF-BP in non-immortalized human keratinocytesH Stöppler, C Malerczyk, K Block, et al.
Zeitschrift Fur Kardiologie|June 1, 1975
[Oxygen transport in the blood of children with congenital heart defects]H Manzke, W Esters, K Dörner, et al.
Pageof 9